The Burden Of Musculoskeletal Conditions At The...
The cost of treating major musculoskeletal diseases, which often includes long-term pain and disability, is also greater than for treatment of many other common health conditions. Yet research dollars to identify causes, create new treatments, and reduce pain and disability remain much lower than that of other health conditions.
The burden of musculoskeletal conditions at the...
With the aging of the US population, musculoskeletal diseases are becoming a greater burden every year. The pages of this site illustrate the magnitude of musculoskeletal diseases on the US population, and provide a small slice of the cost and impact on the US economy.
Musculoskeletal conditions are also the highest contributor to the global need for rehabilitation. They are among the largest contributors to the need for rehabilitation services among children and account for approximately two-thirds of all adults in\r\n need of rehabilitation (1). Musculoskeletal conditions often co-exist with other noncommunicable diseases and increase the risk of developing other noncommunicable diseases, such as cardiovascular disease (2). People with musculoskeletal conditions\r\n are also at higher risk to develop mental health issues.
Low back pain is the main contributor to the overall burden of musculoskeletal conditions (570 million prevalent cases worldwide, responsible for 7.4% of global YLDs). Other contributors to the overall burden of musculoskeletal conditions include fractures\r\n with 440 million people globally (26 million YLDs), osteoarthritis (528 million people; 19 million YLDs), neck pain (222 million people; 22 million YLDs), amputations (180 million people; 5.5 million YLDs), rheumatoid arthritis (18 million people;\r\n 2.4 million YLDs), gout (54 million people; 1.7 million YLDs) other musculoskeletal conditions (453 million people; 38 million YLDs) [data from IHME Viz Hub and WHO Rehabilitation Needs Estimator].
The WHO Rehabilitation Need Estimator tool provides a unique opportunity to search for country, regional or global prevalence and YLD data on musculoskeletal conditions that can benefit\r\n from rehabilitation, based on GBD 2019 data. Similarly, the GBD Compare Tool also provides health estimates for musculoskeletal and other conditions. Variation in aggregated health\r\n estimates between the tools may be explained by differences in which specific musculoskeletal conditions and subgroups of those are included.
WHO is also developing a Package of Interventions for Rehabilitation including the following musculoskeletal conditions: low back pain, osteoarthritis, rheumatoid arthritis, sarcopenia, fractures in the extremities, and amputation. Each package will contain\r\n a list of essential interventions for rehabilitation and the resources required to deliver them safely and effectively. These interventions will be relevant for people at all stages of life, along the continuum of care, across all service delivery\r\n platforms, and across all world regions, with a specific focus on low- and middle-resource contexts.
Musculoskeletal conditions are also the highest contributor to the global need for rehabilitation. They are among the largest contributors to the need for rehabilitation services among children and account for approximately two-thirds of all adults inneed of rehabilitation (1). Musculoskeletal conditions often co-exist with other noncommunicable diseases and increase the risk of developing other noncommunicable diseases, such as cardiovascular disease (2). People with musculoskeletal conditionsare also at higher risk to develop mental health issues.
Low back pain is the main contributor to the overall burden of musculoskeletal conditions (570 million prevalent cases worldwide, responsible for 7.4% of global YLDs). Other contributors to the overall burden of musculoskeletal conditions include fractureswith 440 million people globally (26 million YLDs), osteoarthritis (528 million people; 19 million YLDs), neck pain (222 million people; 22 million YLDs), amputations (180 million people; 5.5 million YLDs), rheumatoid arthritis (18 million people;2.4 million YLDs), gout (54 million people; 1.7 million YLDs) other musculoskeletal conditions (453 million people; 38 million YLDs) [data from IHME Viz Hub and WHO Rehabilitation Needs Estimator].
The WHO Rehabilitation Need Estimator tool provides a unique opportunity to search for country, regional or global prevalence and YLD data on musculoskeletal conditions that can benefitfrom rehabilitation, based on GBD 2019 data. Similarly, the GBD Compare Tool also provides health estimates for musculoskeletal and other conditions. Variation in aggregated healthestimates between the tools may be explained by differences in which specific musculoskeletal conditions and subgroups of those are included.
WHO is also developing a Package of Interventions for Rehabilitation including the following musculoskeletal conditions: low back pain, osteoarthritis, rheumatoid arthritis, sarcopenia, fractures in the extremities, and amputation. Each package will containa list of essential interventions for rehabilitation and the resources required to deliver them safely and effectively. These interventions will be relevant for people at all stages of life, along the continuum of care, across all service deliveryplatforms, and across all world regions, with a specific focus on low- and middle-resource contexts.
Musculoskeletal conditions are extremely common and include more than 150 different diseases and syndromes, which are usually associated with pain and loss of function. In the developed world, where these conditions are already the most frequent cause of physical disability, ageing of the most populous demographic groups will further increase the burden these conditions impose. In the developing world, successful care of childhood and communicable diseases and an increase in road traffic accidents is shifting the burden to musculoskeletal and other noncommunicable conditions. To help better prepare nations for the increase in disability brought about by musculoskeletal conditions, a Scientific Group meeting was held to map out the burden of the most prominent musculoskeletal conditions at the start of the Bone and Joint Decade. In particular, the Group gathered data on the incidence and prevalence of rheumatoid arthritis, osteoarthritis, osteoporosis, major limb trauma and spinal disorders. Data were collected and organized by world region, gender and age groups to assist with the ongoing WHO Global Burden of Disease 2000 study. The Group also considered what is known about the severity and course of these conditions, along with their economic impact. The most relevant domains to assess and monitor the consequences of these conditions were identified and used to describe health states for the different stages of the conditions. Instruments that measure these most important domains for the different conditions were recommended. It is clear from data collated that the impact from musculoskeletal conditions and trauma varies among different parts of the world and is influenced by social structure, expectation and economics, and that it is most difficult to measure impact in less developed nations, where the predicted increase is greatest.
US Bone and Joint Decade organizations, including the American Academy of Orthopaedic Surgeons (AAOS), have published an update on The Burden of Musculoskeletal Disease in the United States . These organizations have collaborated to tabulate recent data on the burden of musculoskeletal diseases to educate health care professionals, policy makers, and the public.
The preface to the report was written by NIAMS Director Stephen I. Katz, M.D., Ph.D. "Although many advances have been made, musculoskeletal conditions remain common, chronic, and costly," according to Dr. Katz's preface. "This publication examines such public health issues as spinal problems, arthritis and joint pain, osteoporosis, injuries, congenital conditions, neoplasms, and health care utilization and costs."
The Bone and Joint Decade is an international collaborative movement sanctioned by the United Nations World Health Organization. The Decade was officially proclaimed in the United States by the President for 2002-2011. Participating organizations of the Bone and Joint Decade are engaged in developing new research and education programs that will bring about significant advances in the knowledge, diagnosis and treatment of musculoskeletal conditions, and increase the number of resources at the disposal of the healthcare professions and the public at large.
As musculoskeletal conditions continue to drive high costs for you and your employees, it's time to move beyond fragmented care journeys to a more personalized path that positions your employees, and your business, for optimal health and growth.
This report presents findings from the Australian Burden of Disease Study 2011 on the burden of musculoskeletal conditions in Australia. Musculoskeletal conditions were the fourth leading contributor to total burden of disease in Australia, with back pain and problems, osteoarthritis and rheumatoid arthritis being the greatest contributors to the musculoskeletal burden. The burden due to musculoskeletal conditions generally decreased over time, varied by condition severity and by population group, and some of the burden was attributed to modifiable risk factors such as overweight and obesity.
Musculoskeletal conditions, such as various forms of arthritis and back pain and problems, are common long-term conditions affecting the bones, muscles and connective tissues. These conditions contribute substantially to the disease burden within the Australian population. Burden of disease analysis measures the combined impact of living with illness and injury (non-fatal burden) and dying prematurely (fatal burden). This report presents detailed information on the disease burden due to musculoskeletal conditions by age, sex, population groups and over time using data from the Australian Burden of Disease Study (ABDS) 2011. 041b061a72